CliffBio
small molecule

IMPLANON

ETONOGESTREL

Loss of exclusivityJuly 2030latest FDA-listed patent expiry
CompanyOrganon →View the full company profile on CliffBio

Drug detail

Brand nameIMPLANON
Active ingredientETONOGESTREL
Strength68MG/IMPLANT
Dosage formIMPLANT
RouteIMPLANTATION
ModalitySmall molecule
FDA approvalJuly 2006
Marketing statusDISCN

Listed patents

PatentExpiresType
9757552July 2030product

More from Organon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

IMPLANON patent cliff — loss of exclusivity July 2030 | CliffBio